According to Future Market Insights (FMI), sales for menopause supplements are expected to reach US$ 934.8 million in 2024. The market is set to attain a value of US$ 1,429.2 million, expanding at a CAGR of 5.7% by 2034.
The acceptance and awareness of menopause as a natural phase of life is pushing demand for natural and holistic approaches to health. It is also augmenting advancements in product formulation and development. These factors contribute to the growing consumer interest in menopause supplements and propel sales.
Request Sample Report and Drive Impactful Decisions: https://www.futuremarketinsights.com/reports/sample/rep-gb-19371
Growing demand for natural solutions, transparency in product labeling & quality assurance, and emphasis on evidence-based formulations backed by scientific research are expected to fuel the market. The rising trend toward customized healthcare has led to a surging demand for menopause supplements tailored to individual needs, considering factors like age, symptoms, hormone levels, and health conditions.
Marketing strategies focus on holistic wellness, including supplements, for managing menopause symptoms. Leading manufacturers prioritize safety and efficacy. They are utilizing regulatory standards and quality assurance measures like GMP and third-party testing to influence consumer-purchasing decisions.
Key Takeaways from the Menopause Supplement Market Report:
- The global menopause supplement market is expected to reach a valuation of US$ 934.8 million by 2024.
- Global demand for menopause supplements is set to soar at 5.7% CAGR over the forecast period.
- North America is projected to hold a dominant value share of 32.2% in the global market by 2034.
- Europe’s menopause supplement market is projected to grow with a CAGR of 6.8% during the forecast period.
- The United States is expected to reach US$ 290.1 million by 2034.
“The market is expected to benefit from evolving consumer preferences toward natural & herbal ingredients, increased spending on premium menopause supplements, and an aging population. The menopause supplement market is also influenced by the shift toward online shopping and e-commerce platforms, driven by consumer preference for convenience and growth in retail channels.” -says a lead analyst at Future Market Insights (FMI).
Competitive Landscape
Nature’s Bounty Co., NOW Foods, Pfizer Inc., Bayer AG, GlaxoSmithKline (GSK), GNC Holdings, Inc., and Reckitt Benckiser Group plc are the key players in the market. Leading companies are expanding their product portfolios, employing advertising, partnerships, acquisitions, agreements, and mergers to maintain market relevance and push growth in the menopause supplement market.
The menopause supplement market has a diverse and dynamic competitive landscape. Leading companies specializing in diverse fields focus on research & development, sustainable sourcing, and new formulations. Key companies emphasize environmentally friendly practices, product certifications, and satisfying the increased demand for natural and sustainable ingredients.
For instance,
- In 2022, PharmaLinea launched a menopause supplement known as “whole body” that offers pain relief benefiting cardio-metabolic and improving gut health.
- In 2023, HANX, a start-up company, launched new supplements for menopause and pregnancy support, promising to provide much-needed help to women during critical life stages.
Get More Valuable Insights
Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global menopause supplement market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.
The study incorporates compelling insights on the menopause supplement market based on product type (hormonal supplements, non-hormonal supplements, nutritional supplements, and others), form (capsules, tablets, liquids, powders, gummies, and soft gels), sales channels (store-based retails and online pharmacies) and regions.
Get full Report: https://www.futuremarketinsights.com/checkout/19371
Global Menopause Supplement Market Segmentation by Category
By Product Type:
- Hormonal Supplements
- Non-hormonal Supplements
- Nutritional Supplements
- Other
By Form:
- Tablets
- Capsules
- Liquids
- Powders
- Gummies
- Soft Gels
By Sale Channels:
- Store-based
- Modern Trade
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube